Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance

Table 1 Demography of patients characteristic ( N = 108)

Factors	N	Factors	N
Origin		Age
Buccal	47	≤30	2
Tongue	35	31-40	18
Gum	8	41-50	37
Lip	6	51-60	30
Palate	5	61-70	16
Retromolar trigone	4	≥71	5
Mouth floor	3	Smoking
Gender		Ever	86
Male	104	Never	18
Female	4	Unknown	4
T classification		Alcohol
1	38	Ever	50
2	36	Never	50
3	6	Unknown	8
4	28	Betel nut
N classification		Ever	78
0	72	Never	22
1	15	Unknown	8
2	21	Radiation
3	0	Received	66
TNM staging		Not received	33
1	30	Unknown	9
2	24	Chemotherapy
3	13	Received	52
4	41	Not received	46
		Unknown	10

ISSN: 1423-0127